$7.02
At close: Jun 9 EDT
$7.11
0.091.27%
Pre-Market: 7:44 PM EDT
Comments
Loading...
Latest UroGen Pharma Stock News | NASDAQ:URGN | Benzinga
Get the latest news on UroGen Pharma stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on UroGen Pharma performance
Categories: All
Tuesday, June 03, 2025
Monday, June 02, 2025
Sunday, May 25, 2025
Friday, May 23, 2025
Thursday, May 22, 2025
Wednesday, May 21, 2025
Tuesday, May 13, 2025
Monday, May 12, 2025
Friday, May 09, 2025
Thursday, May 08, 2025
Wednesday, May 07, 2025
Tuesday, April 29, 2025
Monday, April 28, 2025
- UroGen Pharma Touts Four-Year Response With Urothelial Cancer Drug Study, Highlights Potential For Bladder Cancer Candidates
- UroGen Pharma shares are trading higher after...
- Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday
- HC Wainwright & Co. Reiterates Buy on UroGen ...
- D. Boral Capital Maintains Buy on UroGen Phar...
- Reported Sunday, UroGen Highlights Nearly Fou...
- Reported Sunday, UroGen Presents New Data Sho...
- Reported Sunday, UroGen's OPTIMA II Study Res...
- Reported Saturday, UroGen Pharma's UGN-102 Ac...
- Reported Saturday, UroGen Pharma's UGN-301 Ph...
